The University of Central Lancashire is proud to present its portfolio of Intellectual Property which covers a wide range of categories, including: Biomedical Sciences, Electrical and Electronic Engineering, Mechanical Engineering, Forensic Sciences, Nuclear Sciences, Materials and Nano-Materials Technologies, Tribology Technologies, Pharmacy and 3D Printing Technologies.
You can review the portfolio here or for more detail about a specific UCLan technology and answers to general questions about working with us or licensing our IP, please contact the innovation team at: firstname.lastname@example.org
UCLan research is developing solutions for the medical equipment market and in particular a dilator product for use in a clinical and home setting.
UCLan`s patented technology enables the removal of pollutants through the use of a relatively inexpensive water-purifying composite material and processing technology that is environmentally benign.
UCLan research has developed novel nanopowders which exhibit colour-tuneability in response to the wavelength of the incident radiation.
UCLan has developed and patented a series of new molecules that we hope one day could be advanced into a much needed new treatment for malignant brain tumours.
UCLan research is developing Rapidly Mutating (RM) YSTRs can differentiate between closely related males. A 13 locus multiplex PCR kit RM-YPlex was developed to simultaneously amplify them, in a robust and sensitive manner down to 0.0625ng template DNA.
UCLan patented research using intelligent signal processing is being used to non-invasively track the increase of fluid in a bladder.
UCLan patented research is utilising aptamers, ligand-binding fragments of aptamers, and oligonucleotides for use as agents in the prevention and/or treatments of cancers, and diagnosis of cancers.